Luo Li

2PUBLICATIONS
0CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 07, 2026
The AUTACE That Degrades KRAS and Engages CD8<sup>+</sup> T Cells for the Treatment of KRAS/TP53 Co-Mutant Tumors.

Luo Li, Bolin Li, Yanan Hao

|Jan 27, 2019
PLCε knockdown overcomes drug resistance to androgen receptor antagonist in castration-resistant prostate cancer by suppressing the wnt3a/β-catenin pathway.

Luo Li, Zhongbo Du, Yingying Gao

Pageof 1

Frequent Collaborators